These are people with RRMS where the disease is very active, the most effective medication does not work and who deteriorate in a short time. Rianne Wisgerhof, Director of the National MS Fund: “We are very pleased that this step has now been taken. Many congratulations to everyone who has worked hard for this.”
international study
Wisgerhof continues: “This is good news for a very small group of people with MS. As the National MS Fund, we therefore invest in the RAM-MS research, an international study into the question of whether more people could be eligible for long-term stem cell therapy. So that in some cases you do not opt for the current highly effective medication, but for stem cell therapy at an earlier time. The proof of that must come from this research.” The MS Research Foundation also invests in this research.
Neurologist Joep Killestein, who is conducting the RAM-MS study with his colleagues, recently spoke on National MS Day about how hard he and other neurologists are trying to make stem cell transplantation possible in the Netherlands. This has paid off. Read the entire message from the National Health Care Institute here.
EenVandaag also paid attention to this news. Read the article here and view the various reactions.
Looking back: Joost Smolders and Joep Killestein
During National MS Day, neurologists Joost Smolders and Joep Killestein answered questions about stem cell therapy. They also provided clear explanations about this method of treatment. You can watch the session here.